Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electro-Acupuncture Ameliorated MPTP-Induced Parkinsonism in Mice via TrkB Neurotrophic Signaling.

Frontiers in neuroscience·2019
Same author

Enzyme characterization and biological activities of a resuscitation promoting factor from an oil degrading bacterium <i>Rhodococcus erythropolis</i> KB1.

PeerJ·2019
Same author

MXene Boosted CoNi-ZIF-67 as Highly Efficient Electrocatalysts for Oxygen Evolution.

Nanomaterials (Basel, Switzerland)·2019
Same author

A Biomimetic Hierarchical Nanointerface Orchestrates Macrophage Polarization and Mesenchymal Stem Cell Recruitment To Promote Endogenous Bone Regeneration.

ACS nano·2019
Same author

Adjacent intact nociceptive neurons drive the acute outburst of pain following peripheral axotomy.

Scientific reports·2019
Same author

Daily intake of soft drinks is associated with symptoms of anxiety and depression in Chinese adolescents.

Public health nutrition·2019
Same journal

Predicting piRNA-Disease Associations Based on Dual-View Learning and Multi-head Self-Attention Mechanism Fusion.

Interdisciplinary sciences, computational life sciences·2026
Same journal

DTANet+: Dual Interaction and Kernel-Diverse Network for Drug-Target Affinity Prediction.

Interdisciplinary sciences, computational life sciences·2026
Same journal

STNMAE: Identifying Spatial Domains from Spatial Transcriptomics Data with Neighbor-Aware Multi-view Masked Graph Autoencoder.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Diagnosis and Prediction of Alzheimer's Disease via a High-Level Convolutional Block Attention Module-Residual Network.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Deep3D-DTA: A Tri-Modal Deep Learning Framework for Binding Affinity Prediction Leveraging 3D Structural Representations of Drugs and Targets.

Interdisciplinary sciences, computational life sciences·2026
Same journal

ST-LDAW: A Topic-Model and Damped Weighted Least-Squares Method for Integrative Deconvolution of Single-Cell and Spatial Transcriptomics.

Interdisciplinary sciences, computational life sciences·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

DynamicDTA: Drug-Target Binding Affinity Prediction Using Dynamic Descriptors and Graph Representation.

Dan Luo1, Jinyu Zhou1, Le Xu1

  • 1School of Computer Science, Xiangtan University, Xiangtan, 411105, China.

Interdisciplinary Sciences, Computational Life Sciences
|June 6, 2025
PubMed
Summary
This summary is machine-generated.

DynamicDTA improves drug-target binding affinity prediction by integrating dynamic protein features. This deep learning framework enhances accuracy over existing methods, aiding drug discovery efforts.

Keywords:
Deep learningDrug discoveryDrug-target binding affinityProtein dynamics

More Related Videos

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Predicting drug-target binding affinity (DTA) is crucial for identifying therapeutic candidates.
  • Existing DTA models often neglect protein dynamics, limiting accuracy.
  • Protein conformational flexibility plays a key role in binding interactions.

Purpose of the Study:

  • To introduce DynamicDTA, a deep learning framework for enhanced DTA prediction.
  • To incorporate both static and dynamic protein features into DTA modeling.
  • To improve the accuracy and reliability of DTA predictions.

Main Methods:

  • DynamicDTA utilizes drug sequences, protein sequences, and dynamic descriptors as input.
  • Graph convolutional networks process drug molecular graphs; dilated convolutions encode protein sequences.
  • Dynamic descriptors are processed via multi-layer perceptrons, fused with static protein features using cross-attention, and integrated via a tensor fusion network.

Main Results:

  • DynamicDTA achieved at least a 3.4% improvement in RMSE score compared to seven state-of-the-art methods across three datasets.
  • The model demonstrated reliability and biological relevance in predicting novel drugs for HIV-1.
  • Visualization of docking complexes further validated the model's predictions.

Conclusions:

  • DynamicDTA offers a significant advancement in DTA prediction by incorporating protein dynamics.
  • The framework enhances accuracy and provides biologically relevant insights for drug discovery.
  • The source code is publicly available, facilitating further research and application.